These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 19158035)
21. Angiostatin. Cao Y; Xue L Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800 [TBL] [Abstract][Full Text] [Related]
22. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways. Roy V; Perez EA Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790 [TBL] [Abstract][Full Text] [Related]
23. Angiogenesis and cancer: recent advances. Cáceres W; González S P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139 [TBL] [Abstract][Full Text] [Related]
25. The role of angiogenesis in the biology and therapy of myelodysplastic syndromes. Aguayo A Curr Hematol Rep; 2004 May; 3(3):184-91. PubMed ID: 15087066 [TBL] [Abstract][Full Text] [Related]
26. The interaction of radiation therapy and antiangiogenic therapy. O'Reilly MS Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126 [TBL] [Abstract][Full Text] [Related]
27. Angiogenesis and breast cancer. Hayes DF Hematol Oncol Clin North Am; 1994 Feb; 8(1):51-71. PubMed ID: 7512088 [TBL] [Abstract][Full Text] [Related]
28. Hemostatic complications of angiogenesis inhibitors in cancer patients. Elice F; Jacoub J; Rickles FR; Falanga A; Rodeghiero F Am J Hematol; 2008 Nov; 83(11):862-70. PubMed ID: 18819092 [TBL] [Abstract][Full Text] [Related]
29. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results]. Mazeron R; Bourhis J; Deutsch E Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308 [TBL] [Abstract][Full Text] [Related]
30. Angiogenesis and gliomas: current issues and development of surrogate markers. Jouanneau E Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890 [TBL] [Abstract][Full Text] [Related]
31. Novel strategies towards the use of anti-angiogenic agents in breast cancer. Bakker JL; Meijers-Heijboer H; Verheul H Eur J Pharmacol; 2013 Oct; 717(1-3):36-9. PubMed ID: 23545363 [TBL] [Abstract][Full Text] [Related]
33. Prior exposure to chemotherapy: a marker of sensitivity and selection for antiangiogenic therapy in breast cancer? Xynos ID; Tanna N; Patten DK; Palmieri C Expert Rev Anticancer Ther; 2014 Feb; 14(2):163-72. PubMed ID: 24308686 [TBL] [Abstract][Full Text] [Related]
34. Molecular targets as therapeutic strategies in the management of breast cancer. Sartor CI Semin Radiat Oncol; 2002 Oct; 12(4):341-51. PubMed ID: 12382192 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of angiogenesis and invasion in malignant gliomas. Chi A; Norden AD; Wen PY Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923 [TBL] [Abstract][Full Text] [Related]
37. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era. Wagner AD; Moehler M Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of disease: angiogenesis and the management of breast cancer. Banerjee S; Dowsett M; Ashworth A; Martin LA Nat Clin Pract Oncol; 2007 Sep; 4(9):536-50. PubMed ID: 17728712 [TBL] [Abstract][Full Text] [Related]
39. [Angiogenesis: all a radiation oncologist should know]. Mazeron R; Bourhis J; Deutsch E Cancer Radiother; 2008 Jan; 12(1):50-60. PubMed ID: 18243753 [TBL] [Abstract][Full Text] [Related]
40. [Anti-angiogenic therapies: from theory to practice]. Bidart M; Berger F; Pelletier L Ann Biol Clin (Paris); 2013; 71(5):527-35. PubMed ID: 24113438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]